project id: TCGA-LIHC; case submitter id: TCGA-G3-A3CG; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.5; age at index: 80; days to birth: -29432; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 29432; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 673.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: Not Reported; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 261; initial weight: 270.0; oct embedded: false; preservation method: Unknown; sample id: d02deece-d8bc-4614-ac26-60a4282fdb07; sample submitter id: TCGA-G3-A3CG-01A; portion id: 30191e3e-f9df-4f1e-bcc3-59381f678daf; portion submitter id: TCGA-G3-A3CG-01A-11; slide id: f9df4f84-9097-4d9a-8eeb-5de3311180bf; slide submitter id: TCGA-G3-A3CG-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 98.0; percent tumor nuclei: 95.0; section location: TOP;